Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies

Kim Lauper*, Denis Mongin, Sytske Anne Bergstra, Denis Choquette, Catalin Codreanu, Jacques-Eric Gottenberg, Satoshi Kubo, Merete Lund Hetland, Florenzo Iannone, Eirik K Kristianslund, Tore K Kvien, Galina Lukina, Xavier Mariette, Dan C Nordström, Karel Pavelka, Manuel Pombo-Suarez, Ziga Rotar, Maria J Santos, Yoshiya Tanaka, Carl TuressonDelphine S Courvoisier, Axel Finckh, Cem Gabay

*Corresponding author af dette arbejde

Fingeraftryk

Dyk ned i forskningsemnerne om 'Oral glucocorticoid use in patients with rheumatoid arthritis initiating TNF-inhibitors, tocilizumab or abatacept: results from the international TOCERRA and PANABA observational collaborative studies'. Sammen danner de et unikt fingeraftryk.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology